user

Integrated Palliative Care for Patients Referred for Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Service Evaluation

被引：4
|
作者：
Williams, Rebekah [1 ,2 ,3 ]
Droney, Joanne [1 ,2 ]
Nicholson, Emma [1 ,2 ]
Gonzalez, Carlos [1 ,2 ]
Ellard, Rose [1 ,2 ]
Bradley, Nathalie [1 ,2 ]
Maycock, Celvin [1 ,2 ]
Halley, Angela [1 ,2 ]
机构：
[1] Royal Marsden Hosp, Symptom Control & Palliat Care Dept, Sutton, England
[2] Royal Marsden Hosp, Haematol Dept, Sutton, England
[3] Royal Marsden Hosp, Fulham Rd, London SW3 6JJ, England
来源：
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2024年 / 67卷 / 02期
关键词：
D O I：
10.1016/j.jpainsymman.2023.11.002
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：e157 / e159
页数：3
相关论文
共 50 条
  • [31] Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Salinas, Ryan D.
    Durgin, Joseph S.
    O'Rourke, Donald M.
    CNS DRUGS, 2020, 34 (02) : 127 - 145
  • [32] GEOGRAPHIC TRENDS IN CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY ACCESS AND UTILIZATION
    McBride, K.
    Snyder, S.
    Serrano-Rubio, D.
    Gitlin, M.
    VALUE IN HEALTH, 2024, 27 (06) : S218 - S218
  • [33] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [34] MANAGEMENT OF COAGULOPATHY ASSOCIATED WITH TISAGENLECLEUCEL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY
    Buechner, Jochen
    Grupp, Stephan A.
    Maude, Shannon L.
    Hiramatsu, Hidefumi
    Teachey, David
    Wood, Patricia
    Awasthi, Rakesh
    Yi, Lan
    De Moerloose, Barbara
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [35] Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Ryan D. Salinas
    Joseph S. Durgin
    Donald M. O’Rourke
    CNS Drugs, 2020, 34 : 127 - 145
  • [36] Chimeric Antigen Receptor (CAR) T-cell therapy; a promising outlook for refractory malignancies
    Haider, Syed Ali
    Tariq, Syed Maaz
    Hasan, Mohammad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2018, 68 (09) : 1422 - 1423
  • [37] Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
    Schubert, M-L
    Schmitt, M.
    Wang, L.
    Ramos, C. A.
    Jordan, K.
    Mueller-Tidow, C.
    Dreger, P.
    ANNALS OF ONCOLOGY, 2021, 32 (01) : 34 - 48
  • [38] Cardiac effects of chimeric antigen receptor (CAR) T-cell therapy in children.
    Burstein, Danielle S.
    Maude, Shannon L.
    Grupp, Stephan A.
    Griffis, Heather
    Rossano, Joseph W.
    Lin, Kimberly Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses
    Riedell, Peter A.
    Wu, Meng
    Collins, Jennifer M.
    Gideon, Jacklyn M.
    Jakubowiak, Andrzej J.
    Kline, Justin P.
    Kosuri, Satyajit
    Liu, Hongtao
    Smith, Sonali M.
    Bishop, Michael R.
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1497 - 1501
  • [40] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR ASPERGILLOSIS
    Kumar, P.
    Wurster, S.
    daSilva, T.
    Hauser, P.
    Neelapu, S. S.
    Kontoyiannis, D.
    CYTOTHERAPY, 2024, 26 (06) : S10 - S11
12345